Summary
[Asia Pacific Pharmaceuticals: The company’s shareholding structure is relatively dispersed and there is a risk of changes in controlling rights]Asia Pacific Pharmaceuticals (002370) announced on the evening of June 24 that the company’s controlling shareholder, Asia Pacific Group and its concerted actors, were judicially dealt with due to financial loan contract disputes. The company held 76.5 million shares, accounting for 14.26% of the company’s total share capital; Ningbo Bank Shaoxing branch obtained 39 million shares of the company by way of equity debt due to the execution of the court ruling, accounting for 7.27% of the company’s total share capital. After this equity change, the company’s shareholding structure is relatively dispersed, and there is a risk of change in controlling rights. (E company)
Asia Pacific Pharmaceutical(002370) Evening of June 24announcement, Company holdingshareholderThe Asia-Pacific Group and its concerted parties due to financial borrowingscontractThe disputes totaled 76.5 million shares of the company held by it, which accounted for 14.26% of the company’s total share capital;Bank of NingboThe Shaoxing branch obtained 39 million shares of the company in the form of equity debt due to the execution of the court’s ruling, accounting for 7.27% of the company’s total share capital. After this equity change, the company’s shareholding structure is relatively dispersed, and there is a risk of change in controlling rights.
(Article source: e company)
.